Law Offices of Charles J. Piven, P.A. Announces the Filing of a Class Action Suit Against INVESCO Funds Group, Inc. and Its INVESCO Funds -- ILSAX, IMGAX, IAMSX, ISPIX


BALTIMORE, Dec. 3, 2003 (PRIMEZONE) -- Law Offices Of Charles J. Piven, P.A. announces that a class action lawsuit has been filed in the United States District Court for the District of Colorado on behalf of all purchasers of INVESCO Advantage Health Sciences Fund (Nasdaq:IAGHX), (Nasdaq:IGHBX), (Nasdaq:IGHCX); INVESCO Core Equity Fund (Nasdaq:ICEAX), (Nasdaq:ICEBX), (Nasdaq:IINCX), (Nasdaq:FIIIX), (Nasdaq:IEIKX); INVESCO Dynamics Fund (Nasdaq:IDYAX), (Nasdaq:IDYBX), (Nasdaq:IFDCX; Nasdaq:FIDYX; Nasdaq:IDYKX); INVESCO Energy Fund (Nasdaq:IENAX; Nasdaq:IENBX), (Nasdaq:IEFCX; Nasdaq:FSTEX; Nasdaq:IENKX); INVESCO Financial Services Fund (Nasdaq:IFSAX; Nasdaq:IFSBX; Nasdaq:IFSCX), (Nasdaq:FSFSX), (Nasdaq:FSFKX); and other Invesco Mutual Funds that are managed by Invesco Funds Group, Inc. ("Invesco"), which is a subsidiary of Amvescap PLC (NYSE:AVZ; "Amvescap") from December 5, 1998 through November 24, 2003, inclusive (the "Class Period"), seeking to pursue remedies under the Securities Act of 1933, the Securities Exchange Act of 1934 and the Investment Company Act of 1940.

The Funds and the symbols for the respective Funds subject to the lawsuit are as follows:


 -- INVESCO Advantage Health Sciences Fund (Nasdaq:IAGHX),
    (Nasdaq:IGHBX), (Nasdaq:IGHCX)
 -- INVESCO Core Equity Fund (Nasdaq:ICEAX), (Nasdaq:ICEBX),
    (Nasdaq:IINCX), (Nasdaq:FIIIX), (Nasdaq:IEIKX)
 -- INVESCO Dynamics Fund (Nasdaq:IDYAX), (Nasdaq:IDYBX),
    (Nasdaq:IFDCX; Nasdaq:FIDYX; Nasdaq:IDYKX)
 -- INVESCO Energy Fund (Nasdaq:IENAX; Nasdaq:IENBX),
    (Nasdaq:IEFCX; Nasdaq:FSTEX; Nasdaq:IENKX)
 -- INVESCO Financial Services Fund (Nasdaq:IFSAX; Nasdaq:IFSBX;
    Nasdaq:IFSCX), (Nasdaq:FSFSX), (Nasdaq:FSFKX)
 -- INVESCO Gold & Precious Metals Fund (Nasdaq:IGDAX),
    (Nasdaq:IGDBX; Nasdaq:IGDCX; Nasdaq:FGLDX)
 -- INVESCO Health Sciences Fund (Nasdaq:IAHSX; Nasdaq:IBHSX;
    Nasdaq:IHSCX; Nasdaq:FHLSX), (Nasdaq:IHSKX)
 -- INVESCO International Core Equity Fund (Nasdaq:IBVAX;
    Nasdaq:IBVBX; Nasdaq:IBVCX), (Nasdaq:IIBCX)
 -- INVESCO Leisure Fund (Nasdaq:ILSAX; Nasdaq:ILSBX),
    (Nasdaq:IVLCX; Nasdaq:FLISX), (Nasdaq:ILEKX)
 -- INVESCO Mid-Cap Growth Fund (Nasdaq:IMGAX; Nasdaq:IMGBX;
    Nasdaq:IMGCX), (Nasdaq:IVMIX)
 -- INVESCO Multi-Sector Fund (Nasdaq:IAMSX), (Nasdaq:IBMSX),
    (Nasdaq:ICMSX)
 -- INVESCO S&P 500 Index Fund (Nasdaq:ISPIX)
 -- INVESCO Small Company Growth Fund (Nasdaq:ISGAX),
    (Nasdaq:ISGBX; Nasdaq:ISGCX), (Nasdaq:FIEGX)
 -- INVESCO Technology Fund (Nasdaq:ITYAX; Nasdaq:ITYBX;
    Nasdaq:ITHCX), (Nasdaq:FTCHX), (Nasdaq:ITHKX)
 -- INVESCO Total Return Fund (Nasdaq:IATRX), (Nasdaq:IBTRX),
    (Nasdaq:ITRCX), (Nasdaq:FSFLX)
 -- INVESCO Utilities Fund (Nasdaq:IAUTX), (Nasdaq:IBUTX),
    (Nasdaq:IUTCX), (Nasdaq:FSTUX)
 -- INVESCO Advantage Fund (Nasdaq:IADAX), (Nasdaq:IADBX),
    (Nasdaq:IADCX)
 -- INVESCO Balanced Fund (Nasdaq:IBLAX),(Nasdaq:IBLBX),
    (Nasdaq:IBNCX), (Nasdaq:IBFIX), (Nasdaq:IMABX), (Nasdaq:IBLKX)
 -- INVESCO European Fund (Nasdaq:IEUAX), (Nasdaq:IEUBX),
    (Nasdaq:FEURX), (Nasdaq:IEUKX)
 -- INVESCO Growth Fund (Nasdaq:IAGWX), (Nasdaq:IBGWX),
    (Nasdaq:IBGCX), (Nasdaq:FLRFX), (Nasdaq:IGWKX)
 -- INVESCO High-Yield Fund (Nasdaq:IAHYX), (Nasdaq:IBHYX),
    (Nasdaq:IHYCX), (Nasdaq:FHYPX), (Nasdaq:IHYKX)
 -- INVESCO Growth & Income Fund, (Nasdaq:IGIAX), (Nasdaq:IGIBX),
    (Nasdaq:IGRCX; Nasdaq:IVGIX), (Nasdaq:IGIKX)
 -- INVESCO International Blue Chip Value Fund (Nasdaq:IBVAX),
    (Nasdaq:IBVBX), (Nasdaq:IBVCX; Nasdaq:IIBCX)
 -- INVESCO Real Estate Opportunity Fund (Nasdaq:IAREX),
    (Nasdaq:IBREX), (Nasdaq:IRECX), (Nasdaq:IVSRX)
 -- INVESCO Select Income Fund (Nasdaq:IASIX), (Nasdaq:IBSIX),
    (Nasdaq:ISICX), (Nasdaq:FBDSX)
 -- INVESCO Tax-Free Bond Fund (Nasdaq:IXBAX), (Nasdaq:IXBBX),
    (Nasdaq:ITFCX), (Nasdaq:FTIFX)
 -- INVESCO Telecommunications Fund (Nasdaq:ITLAX), (Nasdaq:ITLBX;
    Nasdaq:INTCX), (Nasdaq:ISWCX), (Nasdaq:ITEKX)
 -- INVESCO U.S. Government Securities Fund (Nasdaq:IGVAX),
    (Nasdaq:IGVBX), (Nasdaq:IUGCX), (Nasdaq:FBDGX)
 -- INVESCO Value Fund (Nasdaq:IAVEX), (Nasdaq:IBVEX),
    (Nasdaq:IVACX), (Nasdaq:FSEQX)

The wrongful conduct alleged in and which is the subject of the lawsuit relates to "timing." As used, "timing" is an investment technique involving short-term, "in and out" trading of mutual fund shares to turn a quick profit. The lawsuit alleges that timing injures ordinary mutual fund investors who are not allowed to engage in such practices and benefits the mutual fund companies.

No class has yet been certified in the lawsuit. Until a class is certified, you are not represented unless you retain an attorney. If you are a member of the proposed class, meaning you are one who purchased any of the mutual funds referenced herein during the Class Period, you may be eligible to serve as a plaintiff. To be a member of the class, if certified, you need not take any action at this time. You may retain counsel of your choice. If you bought shares of any of the funds between December 5, 1998 through November 24, 2003, inclusive, and you wish to serve as lead plaintiff, a motion must be filed with the Court no later than February 2, 2004.

If you are one who purchased any of the mutual funds referenced above during the Class Period and want to discuss your legal rights, or if you have information or questions about other mutual fund companies being investigated for improper conduct, you may e-mail or call Law Offices Of Charles J. Piven, P.A. who will, without obligation or cost to you, attempt to answer your questions. Law Offices Of Charles J. Piven has been involved in securities litigation for over ten years. You may contact Law Offices Of Charles J. Piven, P.A. at The World Trade Center-Baltimore, 401 East Pratt Street, Suite 2525, Baltimore, Maryland 21202, by email at, hoffman@pivenlaw.com, or by calling 410/986-0036.

More information on this and other class actions can be found on the Class Action Newsline at, www.primezone.com/ca .



            

Kontaktdaten